Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma

被引：0

作者：

Kumar, Shaji ^{[1
]}

Kaufman, Jonathan L. ^{[2
]}

Mikhael, Joseph ^{[3
]}

Gasparetto, Cristina ^{[4
]}

Vij, Ravi ^{[5
]}

Pegourie, Brigitte ^{[6
]}

Benboubker, Lofti ^{[7
]}

Facon, Thierry ^{[8
]}

Moreau, Philippe ^{[9
]}

Amiot, Martine ^{[10
]}

Alzate, Stefanie ^{[11
]}

Dunbar, Martin ^{[11
]}

Xu, Tu ^{[11
]}

Agarwal, Suresh ^{[11
]}

Leverson, Joel ^{[11
]}

Ross, Jeremy ^{[11
]}

Maciag, Paulo ^{[11
]}

Verdugo, Maria ^{[11
]}

Touzeau, Cyrille ^{[12
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[3] Mayo Clin, Scottsdale, AZ USA

[4] Duke Univ, Hematol Malignancies & Cellular Therapy, Durham, NC 27706 USA

[5] Washington Univ, Sch Med, St Louis, MO 63110 USA

[6] CHU, Paris, France

[7] CHRU Hop Bretonneau, Paris, France

[8] Hop Claude Huriez, Serv Malad Sang, Lille, France

[9] Univ Hosp Hotel Dieu, Nantes, France

[10] CHU Nantes, Nantes, France

[11] AbbVie Inc, N Chicago, IL USA

[12] CHU Nantes, Nantes, France

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期

关键词：

D O I：

10.1016/j.clml.2017.03.046

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OP-045

引用

页码：E27 / E27

页数：1

共 50 条

[21] Safety and Efficacy of Venetoclax Salvage Therapy in Relapsed/Refractory Multiple Myeloma with and without t(11;14) [J].

Steinhardt, Maximilian J. ;

Bittrich, Max ;

Zhou, Xiang ;

Noderer, Julia ;

Riedhammer, Christine ;

Xiao, Xianghui ;

Gawlas, Sophia ;

Weis, Philipp ;

Eisele, Florian ;

Munawar, Umair ;

Han, Seungbin ;

Mersi, Julia ;

Waldschmidt, Johannes M. ;

Einsele, Hermann ;

Rasche, Leo ;

Kortuem, K. Martin .

BLOOD, 2023, 142

[22] Correlative biomarkers of response to venetoclax monotherapy in patients with relapsed/refractory multiple myeloma [J].

Ross, Jeremy ;

Chyla, Brenda ;

Goswami, Rasna ;

Roberts-Rapp, Lisa ;

Sun, Yan ;

Jiang, Yanwen ;

Punnoose, Elizabeth ;

Verdugo, Maria ;

Bhathena, Anahita ;

Maciag, Paulo .

CANCER RESEARCH, 2017, 77

[23] NK cell therapy in relapsed refractory multiple myeloma [J].

Roshandel, Elham ;

Ghaffari-Nazari, Haniyeh ;

Mohammadian, Mozhdeh ;

Salimi, Maryam ;

Abroun, Saeid ;

Mirfakhraie, Reza ;

Hajifathali, Abbas .

CLINICAL IMMUNOLOGY, 2023, 246

[24] Bendamustine therapy for advanced relapsed/refractory multiple myeloma [J].

Shkury, Eden ;

Geva, Mika ;

Avigdor, Abraham ;

Nevo, Lee ;

Magen, Hila .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S189-S189

[25] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA [J].

Okada, K. ;

Okamoto, Y. ;

Tsukamoto, T. ;

Sugiura, H. ;

Matsui, H. ;

Ueda, T. ;

Jo, T. ;

Onishi, T. ;

Kunitomi, A. ;

Ueda, Y. .

ANNALS OF ONCOLOGY, 2013, 24

[26] Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. [J].

Moreau, Philippe ;

Chanan-Khan, Asher Alban Akmal ;

Roberts, Andrew Warwick ;

Agarwal, Amit ;

Facon, Thierry ;

Kumar, Shaji ;

Touzeau, Cyrille ;

Diehl, Susan ;

Cordero, Jaclyn ;

Ross, Jeremy A. ;

Munasinghe, Wijith ;

Zhu, Ming ;

Salem, Ahmed H. ;

Leverson, Joel ;

Maciag, Paulo Cesar ;

Verdugo, Maria E. ;

Harrison, Simon J. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[27] Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: a meta-analysis [J].

Xiaohui Gao ;

Hui Zeng ;

Xiaoyan Zhao ;

Haibing Wu ;

Minchao Yan ;

Yuan Li ;

Gang Zhang ;

Fei Sun .

BMC Cancer, 23

[28] A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma [J].

Kambhampati, Swetha ;

Galligan, Derek ;

Ledergor, Guy ;

Martin, Thomas G., III ;

Wolf, Jeffrey ;

Wong, Sandy W. ;

Shah, Nina D. .

BLOOD, 2019, 134

[29] A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma [J].

Galligan, Derek ;

Shah, Nina ;

Wolf, Jeffrey ;

Wong, Sandy ;

Abramovitz, Linda ;

Donnelly, Brenn ;

Narayan, Rupa ;

Mannis, Gabriel ;

Arora, Shagun ;

Marsala, Amy ;

Cerejo, Miguel ;

Martin, Thomas .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 :S339-S339

[30] Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma [J].

Schjesvold, Fredrik ;

Paiva, Bruno ;

Ribrag, Vincent ;

Rodriguez-Otero, Paula ;

San-Miguel, Jesus F. ;

Robak, Pawel ;

Hansson, Markus ;

Onishi, Maika ;

Hamidi, Habib ;

Malhi, Vikram ;

Dail, Monique ;

Javery, Apurva ;

Ku, Grace ;

Raab, Marc S. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01) :E59-E70

← 1 2 3 4 5 →